Continued Pressure for Alveolar Protection (CPAP Trial)

Recruiting now · Not applicable

Conditions studied: Bronchopulmonary Dysplasia (BPD)

In brief

The objective of the CPAP Trial is to test whether extending CPAP until 34 weeks' PMA or for at least 2 additional weeks compared to weaning to a nasal canula will decrease the likelihood of bronchopulmonary dysplasia or death at 36 weeks' PMA.

Key facts

Study ID
NCT07417111
Run by
NICHD Neonatal Research Network
People needed
860
Starts
2026-11-05
Expected to finish
2029-01-30
Last updated by the study team
2026-07-14

Who can join

Age: any, up to 1. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.